Tealwood Asset Management’s Pfizer PFE Stock Holding History

Tealwood Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-139,064	Closed	-$4.68M	–	98
2018 Q1	$4.68M	Buy	139,064 +1,384	+1%	+$47.6K	1.86%	7
2017 Q4	$4.73M	Sell	137,680 -3,515	-2%	-$120K	1.75%	14
2017 Q3	$4.78M	Sell	141,195 -689	-0.5%	-$22.1K	1.72%	14
2017 Q2	$4.52M	Buy	141,884 +6,320	+5%	+$199K	1.69%	17
2017 Q1	$4.4M	Buy	135,564 +1,758	+1%	+$55.4K	1.74%	18
2016 Q4	$4.12M	Buy	133,806 +6,042	+5%	+$184K	1.72%	18
2016 Q3	$4.11M	Sell	127,764 -6,967	-5%	-$233K	1.82%	15
2016 Q2	$4.5M	Buy	134,731 +299	+0.2%	+$9.54K	2.03%	14
2016 Q1	$3.78M	Sell	134,432 -443	-0.3%	-$12.7K	1.7%	22
2015 Q4	$3.9M	Sell	134,875 -4,090	-3%	-$129K	1.83%	17
2015 Q3	$4.14M	Buy	138,965 +543	+0.4%	+$17.4K	1.81%	17
2015 Q2	$4.4M	Buy	+138,422	New	+$4.51M	1.72%	17

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tealwood Asset Management's PFE Position: Q2 2018 in Review

Tealwood Asset Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 139,064 shares — an estimated $4.68M sold.

Tealwood Asset Management first reported a position in PFE in Q2 2015 and held it in 12 quarters. The position peaked at $4.78M in Q3 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Tealwood Asset Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Tealwood Asset Management sold 139,064 Pfizer shares in Q2 2018, an estimated $4.68M.
Tealwood Asset Management first reported a position in Pfizer in Q2 2015 and held it in 12 quarters.
Tealwood Asset Management's Pfizer position peaked at $4.78M in Q3 2017.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Tealwood Asset Management's 13F filing for Q2 2018, filed 25 Jul 2018.